Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors - Early experience

Clinical Neurology and Neurosurgery

Volumn 113, Issue 2, 2011, Pages 156-161

  Lam, Winnie Wing Chuen ^a   Ng, David Chee Eng ^a   Wong, Wai Yin ^a   Ong, Seng Chuan ^b   Yu, Sidney Wing Kwong ^a   See, Siew Ju ^c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

^c NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

Author keywords

18F fluorocholine; 18F fluorodeoxyglucose; PET CT; Primary brain tumors

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLINE DERIVATIVE; FLUOROCHOLINE F 18; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN REGION; BRAIN TUMOR; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CAUSE OF DEATH; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG UPTAKE; FEMALE; GLIOBLASTOMA; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIMARY TUMOR; THALAMUS; TUMOR CLASSIFICATION; TUMOR RECURRENCE;

BRAIN NEOPLASMS; CHOLINE; FATAL OUTCOME; FEMALE; FLUORINE RADIOISOTOPES; GLIOBLASTOMA; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OLIGODENDROGLIOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79151480423     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2010.09.012     Document Type: Article

References (34)

1. D.R. Macdonald, T.L. Cascino, S.C. Schold Jr., and J.G. Cairncross Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 7 1990 1277 1280
2. P.Y. Wen, D.R. Macdonald, D.A. Reardon, T.F. Cloughesy, A.G. Sorensen, and E. Galanis Updated response assessment criteria for high grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 11 2010 1963 1972
3. T.Z. Wong, G.J. van der Westhuizen, and R.E. Coleman Positron emission tomography imaging of brain tumors Neuroimaging Clin N Am 12 4 2002 615 626
4. P.E. Ricci, J.P. Karis, J.E. Heiserman, E.K. Fram, A.N. Bice, and B.P. Drayer Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? Am J Neuroradiol 19 3 1998 407 413
5. E. Yavin Regulation of phospholipid metabolism in differentiating cells from rat brain cerebral hemispheres in culture. Patterns of acetylcholine phosphocholine, and choline phosphoglycerides labeling from (methyl-14C)choline J Biol Chem 25 5 1976 1392 1397
6. M.A. Yorek, J.A. Dunlap, A.A. Spector, and B.H. Ginsberg Effect of ethanolamine on choline uptake and incorporation into phosphatidylcholine in human Y79 retinoblastoma cells J Lipid Res 27 11 1986 1205 1213
7. R. Katz-Brull, and H. Degani Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method Anticancer Res 16 3B 1996 1375 1380
8. A. Ramirez de Molina, A. Rodriguez-Gonzalez, R. Gutierrez, L. Martínez-Piñeiro, J. Sánchez, and F. Bonilla Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers Biochem Biophys Res Commun 296 3 2002 580 583
9. T.R. DeGrado, S.W. Baldwin, S. Wang, M.D. Orr, R.P. Liao, and H.S. Friedman Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers J Nucl Med 42 12 2001 1805 1814
10. T.R. DeGrado, R.E. Reiman, D.T. Price, S. Wang, and R.E. Coleman Pharmacokinetics and radiation dosimetry of 18F-fluorocholine J Nucl Med 43 1 2002 92 96
11. T.A. Tran, G.N. Fuller, G.J. Whitman, and D.F. Schomer Radiologic-pathologic conferences of the University of Texas M.D. Anderson Cancer Center. Delayed cerebral radiation necrosis Am J Roentgenol 180 1 2003 70
12. J.M. Bruner, R.D. Tien, and W.L. Thorstad Structural changes produced by intracranial tumours and by various forms of antineoplastic therapy 6th ed. D.D. Bigner, R.E. Mc Lendon, J.M. Bruner, Russell & Rubinstein's pathology of the nervous system 2 1998 Hodder Arnold London 464 475
13. P. Littman, H. James, R. Zimmerman, and R. Slater Radionecrosis of the brain presenting as a mass lesion. A case report J Neurol Neurosurg Psychiatry 40 8 1977 827 829
14. N.D. Lorenzo, A. Nolletti, and L. Palma Late cerebral radionecrosis Surg Neurol 10 1978 281 290
15. H. Matsumura, and E.R. Ross Delayed cerebral radionecrosis following treatment of carcinoma of the scalp. Clinicopathologic and ultrastructural study Surg Neurol 12 1979 193 204
16. T.P. Thompson, L.D. Lunsford, and D. Kondziolka Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy Stereotact Funct Neurosurg 73 1-4 1999 9 14
17. S.A. Kwee, M.N. Coel, J. Lim, and J.P. Ko Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation J Neuroimaging 14 3 2004 285 289
18. T. Hara, T. Kondo, and N. Kosaka Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas J Neurosurg 99 3 2003 474 479
19. S.A. Kwee, J.P. Ko, C.S. Jiang, M.R. Watters, and M.N. Coel Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18-fluorocholine PET Radiology 244 2 2007 557 565
20. J.P. Rock, D. Hearshen, L. Scarpace, D. Croteau, J. Gutierrez, and J.L. Fisher Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis Neurosurgery 51 4 2002 912 919 discussion 919-920
21. T. Nakajima, T. Kumabe, M. Kanamori, R. Saito, M. Tashiro, and M. Watanabe Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography Neurol Med Chir (Tokyo) 49 9 2009 394 401
22. K. Ishiwata, K. Kubota, M. Murakami, R. Kubota, T. Sasaki, and S. Ishii Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med 34 11 1993
23. P.L. Jager, W. Vaalburg, J. Pruim, E.G. de Vries, K.J. Langen, and D.A. Piers Radiolabeled amino acids: basic aspects and clinical applications in oncology J Nucl Med 42 3 2001 432 445
24. K. Herholz, T. Holzer, B. Bauer, R. Schroder, J. Voges, and R.I. Ernestus 11C-methionine PET for differential diagnosis of low-grade gliomas Neurology 50 5 1998 1316 1322
25. P. Laverman, O.C. Boerman, F.H. Corstens, and W.J. Oyen Fluorinated amino acids for tumour imaging with positron emission tomography Eur J Nucl Med Mol Imaging 29 5 2002 681 690
26. A. Becherer, G. Karanikas, M. Szabo, G. Zettinig, S. Asenbaum, and C. Marosi Brain tumour imaging with PET: a comparison between [18F] fluorodopa and [11C] methionine Eur J Nucl Med Mol Imaging 30 11 2003 1561 1567
27. W. Chen, D.H. Silverman, S. Delaloye, J. Czernin, N. Kamdar, and W. Pope 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy J Nucl Med 47 6 2006 904 911
28. G. Moulin-Romsee, E. D'Hondt, T. de Groot, J. Goffin, R. Sciot, and L. Mortelmans Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine? Eur J Nucl Med Mol Imaging 34 12 2007 2082 2087
29. J.R. Grierson, and A.F. Shields Radiosynthesis of 3′-deoxy- 3′-[(18F)] fluorothymidine: [(18F)]FLT for imaging of cellular proliferation in vivo Nucl Med Biol 27 2 2000 143 156
30. W. Chen, T. Cloughesy, N. Kamdar, N. Satyamurthy, M. Bergsneider, and L. Liau Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG J Nucl Med 46 6 2005 945 952
31. A.H. Jacobs, A. Thomas, L.W. Kracht, H. Li, C. Dittmar, and G. Garlip 18F-fluoro-L-thymidine and 11C-methylmethione as markers of increased transport and proliferation in brain tumors J Nucl Med 46 12 2005 1948 1958
32. Y. Yamamoto, T.Z. Wong, T.C. Turkington, T.C. Hawk, D.A. Reardon, and R.E. Coleman 3′-Deoxy-3′-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging Mol Imaging Biol 8 6 2006 340 347
33. S.J. Choi, J.S. Kim, J.H. Kim, S.J. Oh, J.G. Lee, and C.J. Kim [18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors Eur J Nucl Med Mol Imaging 32 6 2005 653 659
34. T. Saga, H. Kawashima, N. Araki, J.A. Takahashi, Y. Nakashima, and T. Higashi Evaluation of primary brain tumors with FLT-PET: usefulness and limitations Clin Nucl Med 31 12 2006 774 780